Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"
Date Insider Type Main position Quantity % Market Cap.
20-08-27Tax

General Counsel

997 0.0007%
20-08-27Tax

Chief Financial Officer

256 0.0002%
20-08-27Tax

Executive/Senior Manager

281 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%-10.00% - - 3.6M
-2.41%+0.14%+39.53%+154.43% 1,035B
+1.07%+3.48%+53.75%+50.64% 574B
+1.32%+0.22%+18.35%+65.35% 397B
+0.58%+0.77%+21.19%+15.95% 324B
-0.85%-0.68%+23.44%+14.94% 281B
+0.44%+5.39%+25.86%+35.39% 278B
+1.66%+1.20%-44.41%-47.37% 193B
+0.32%+1.61%+19.48%+63.42% 191B
-0.22%-2.76%+12.08%+61.30% 156B
Average +0.30%+1.68%+18.81%+46.00% 381.1B
Weighted average by Cap. -0.18%+2.39%+28.20%+71.91%
Logo Akorn, Inc.
Akorn Inc. (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment TheraTears Therapy for Your Eyes.
Employees
-
  1. Stock Market
  2. Stocks
  3. AKRXQ Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!